Does NADPH oxidase deficiency cause artery dilatation in humans?

Antioxidants and Redox Signaling

Volumn 18, Issue 12, 2013, Pages 1491-1496

  Loffredo, Lorenzo ^a   Carnevale, Roberto ^a   Sanguigni, Valerio ^b   Plebani, Alessandro ^c   Rossi, Paolo ^b   Pignata, Claudio ^d   De Mattia, Domenico ^e   Finocchi, Andrea ^b   Martire, Baldassarre ^e   Pietrogrande, Maria Cristina ^f   Martino, Silvana ^g   Gambineri, Eleonora ^h   Giardino, Giuliana ^d   Soresina, Anna Rosa ^c   Martino, Francesco ^a   Pignatelli, Pasquale ^a   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF BARI   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROSTANE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

ADULT; ARTERY DILATATION; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; GRANULOMATOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NADPH OXIDASE DEFICIENCY; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; VASOCONSTRICTION;

ADOLESCENT; BLOOD PLATELETS; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CHILD; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; ISOPROSTANES; MALE; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; VASODILATION; YOUNG ADULT;

EID: 84875143983     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4987     Document Type: Review

References (9)

1. Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, and Shah AM. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 8: 691-728, 2006..
2. Green DJ, Jones H, Thijssen D, Cable NT, and Atkinson G. Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter? Hypertension 57: 363-9, 2011..
3. Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE, Uzel G, DeRavin SS, Priel DA, Soule BP, Zarember KA, Malech HL, Holland SM, and Gallin JI. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 363: 2600-2610, 2010..
4. Loffredo L, Marcoccia A, Pignatelli P, Andreozzi P, Borgia MC, Cangemi R, Chiarotti F, and Violi F. Oxidative-stressmediated arterial dysfunction in patients with peripheral arterial disease. Eur Heart J 28: 608-612, 2007..
5. Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, Rossi P, Gattorno M, Rabusin M, Azzari C, Dellepiane RM, Pietrogrande MC, Trizzino A, Di Bartolomeo P, Martino S, Carpino L, Cossu F, Locatelli F, Maccario R, Pierani P, Putti MC, Stabile A, Notarangelo LD, Ugazio AG, Plebani A, and De Mattia D. Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study. Clin Immunol 126: 155-164, 2008..
6. Pignatelli P, Carnevale R, Cangemi R, Loffredo L, Sanguigni V, Stefanutti C, Basili S, and Violi F. Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia. Arterioscler Thromb Vasc Biol 30: 360-367, 2010..
7. van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, Espanol T, Fischer A, Kurenko-Deptuch M, Mouy R, Petropoulou T, Roesler J, Seger R, Stasia MJ, Valerius NH, Weening RS, Wolach B, Roos D, and Kuijpers TW. Chronic granulomatous disease: the European experience. PLoS One 4: e5234, 2009..
8. Violi F, Sanguigni V, Carnevale R, Plebani A, Rossi P, Finocchi A, Pignata C, De Mattia D, Martire B, Pietrogrande MC, Martino S, Gambineri E, Soresina AR, Pignatelli P, Martino F, Basili S, and Loffredo L. Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study. Circulation 120: 1616-1622, 2009..
9. Violi F, Sanguigni V, Loffredo L, Carnevale R, Buchetti B, Finocchi A, Tesauro M, Rossi P, Pignatelli P. Nox2 is determinant for ischemia-induced oxidative stress and arterial vasodilatation: a pilot study in patients with hereditary Nox2 deficiency. Arterioscler Thromb Vasc Biol 26: e131-e132, 2006..